Back to Search
Start Over
Considerations related to comparative clinical studies for biosimilars
- Source :
- Expert Opinion on Drug Safety. 20:265-274
- Publication Year :
- 2021
- Publisher :
- Informa UK Limited, 2021.
-
Abstract
- Introduction: Biosimilar medicines have transformed the healthcare landscape by providing improved access to life-saving medicines at a lower cost. Biosimilars are a distinct category of biologic t...
- Subjects :
- medicine.medical_specialty
030204 cardiovascular system & hematology
03 medical and health sciences
Government Agencies
0302 clinical medicine
medicine
Animals
Humans
Pharmacology (medical)
European Union
Intensive care medicine
Biosimilar Pharmaceuticals
Drug Approval
health care economics and organizations
Biological Products
Clinical Trials as Topic
United States Food and Drug Administration
business.industry
Biosimilar
General Medicine
United States
030220 oncology & carcinogenesis
Pharmacodynamics
Lower cost
business
Biomarkers
Subjects
Details
- ISSN :
- 1744764X and 14740338
- Volume :
- 20
- Database :
- OpenAIRE
- Journal :
- Expert Opinion on Drug Safety
- Accession number :
- edsair.doi.dedup.....5243c84b90232fcf895c95c948a0e365